Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes

Clinical Chemistry
Chi Ho LeeKaren S L Lam

Abstract

Raised circulating adipocyte fatty acid-binding protein (AFABP) concentrations are associated with various adverse health conditions. However, their relationship with mortality remains to be defined, especially in view of the sexual dimorphism of circulating AFABP concentrations. Here we investigated prospectively whether serum AFABP concentrations predict multiple mortality outcomes in men and women alike, using a large clinic-based cohort of individuals with type 2 diabetes, a condition with raised AFABP concentrations. Baseline serum AFABP concentrations were measured in 5305 research participants with a monoclonal antibody-based sandwich immunoassay. The role of circulating AFABP concentrations in predicting mortality outcomes was evaluated by multivariable Cox regression analysis. Among the 5305 participants (59% men) in this study, over a median follow-up of 5 years, there were 512 deaths (19.3 deaths per 1000 person-years). Circulating AFABP concentrations, with higher levels in women at baseline, predicted all-cause mortality (P < 0.001), cardiovascular mortality (P = 0.037), and infection-related deaths (P < 0.002) among all participants. In sex-specific analyses, circulating AFABP concentration was an independent pred...Continue Reading

References

Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeffrey B BoordGökhan S Hotamisligil
Jun 8, 2007·Nature·Masato FuruhashiGökhan S Hotamisligil
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Oct 21, 2009·Breast Cancer Research and Treatment·K HanckeJ M Weiss
Mar 4, 2011·The New England Journal of Medicine·Sreenivasa Rao Kondapally SeshasaiUNKNOWN Emerging Risk Factors Collaboration
Nov 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Kwok Leung OngUNKNOWN FIELD study investigators
Dec 12, 2012·European Journal of Heart Failure·Luc DjousséSusan J Zieman
Feb 5, 2013·Critical Care : the Official Journal of the Critical Care Forum·Chi-Lun HuangWei-Shiung Yang
May 15, 2013·Cell Metabolism·Haiming CaoGökhan S Hotamisligil
Apr 18, 2014·The New England Journal of Medicine·Edward W GreggLinda Geiss
Oct 29, 2015·The New England Journal of Medicine·Mauro TancrediMarcus Lind
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Fiona BraggUNKNOWN China Kadoorie Biobank Collaborative Group
Feb 18, 2017·Mediators of Inflammation·Sebastian R Nielsen, Michael C Schmid
Mar 11, 2017·The American Journal of Pathology·Bingfang HuMin Huang

❮ Previous
Next ❯

Citations

Apr 6, 2021·Frontiers in Immunology·Chi-Ho LeeKaren S L Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.